Now loading.
Please wait.

Menu

Dr. Virendra Kumar Meena

HomeDr. Virendra Kumar Meena
HomeDr. Virendra Kumar Meena
single image

Dr. Virendra Kumar Meena

Designation: Scientist C

Division:Electron Microscopy & Histopathology Group

Educational qualifications:MSc Biotechnology, Ph.D. Chemistry

Date of joining ICMR-NIV: :16th December 2016

  • Contact: 91-020-26006248
  • Email:meena.virendra@gov.in, viren27091988@gmail.com
  • Office: Indian Council of Medical Research-National Institute of Virology Pune Maharashtra - 411001

 

Research Interests:

  • Synthesis and evaluation of targeted molecular imaging probes for in vivo brain imaging.
  • Small molecular and/or Nano-conjugates based theranostic agents for brain disorders.
  • Infection biology of encephalitic flavivirusess

 

ORCID ID:

Researcher ID:

Google Scholar Profile Link

 

List of Publications
  • 1.A Potent Acetylcholinesterase Selective and Reversible Homodimeric Agent based on Tacrine for Theranostics. Virendra Kumar Meena, Shubhra Chaturvedi, Rakesh Kumar Sharma, Anil Kumar Mishra, Puja Panwar Hazari. ACS Molecular Pharmaceutics (2019), 16, 2296-2308.

  • 2. Radiolabeling and Preclinical Evaluation of a New S-Alkylated Cysteine Derivative Conjugated to C-Substituted Macrocycle for Positron Emission Tomography. Surbhi Prakash, Puja Panwar Hazari, Virendra Kumar Meena, and Anil Kumar Mishra. ACS Omega (2018), 3 (6), 6497-6505.

  • 3. Rose Bengal attached and dextran coated gadolinium oxide nanoparticles for potential diagnostic imaging applications. Shailja Kumar, Virendra Kumar Meena, Puja Panwar Hazari, Surinder Kumar Sharma, Rakesh Kumar Sharma. European Journal of Pharmaceutical Sciences (2018), 117, 362-370.

  • 4. [68Ga]/ [188Re] complexed [CDTMP] trans-1,2-cyclohexyldinitrilotetraphosphonic acid as a Theranostic Agent for Skeletal Metastases. Ambika Jaswal, , Virendra Kumar Meena, Surbhi Prakash, Harleen Khurana, Puja Panwar Hazari, Anil Kumar Mishra. Frontiers in Medicine (2017) 4:72.

  • 5. PEG coated and doxorubicin loaded multimodal Gadolinium oxide nanoparticles for simultaneous drug delivery and imaging applications. Shailja Kumar, Virendra Kumar Meena, Puja Panwar Hazari, Rakesh Kumar Sharma. International Journal of Pharmaceutics (2017), 527 (1-2), 142-150.

  • 6. Biotinidase Resistant 68Gallium-Radioligand Based on Biotin/Avidin Interaction for pretargeting: Synthesis and preclinical Evaluation. Surbhi Prakash, Puja Panwar Hazari, Virendra Kumar Meena, Ambika Jaswal, Harleen Khurana, Srikant Kukreti, Anil Kumar Mishra. ACS Bioconjugate Chem., 2016, 27 (11), 2780–2790.

  • 7. FITC-Dextran entrapped and silica coated gadolinium oxide nanoparticles for synchronous optical and magnetic resonance imaging applications. Shailja Kumar, Virendra Kumar Meena, Puja Panwar Hazari, Rakesh Kumar Sharma. International Journal of Pharmaceutics (2016), 506 (1-2), 242-252.

  • 8. Synthesis, Preclinical Evaluation and Molecular Modelling of Macrocyclic Appended 1-(2- methoxyphenyl) piperazine for 5-HT1A Neuroreceptor Imaging. Puja Panwar Hazari, Surbhi Prakash, Virendra Kumar Meena, Niraj Singh, Krishna Chuttani, Nidhi Chadha, Pooja Singh, Srikant Kukreti, Anil Kumar Mishra. RSC Advances (2016) 6, 7288-7301.

  • 9. Preclinical Evaluation of a Potential GSH Ester Based PET/SPECT Imaging Probe DT(GSHMe)₂ to Detect Gamma Glutamyl Transferase Over Expressing Tumors. Khurana H, Meena VK, Prakash S, Chuttani K, Chadha N, Jaswal A, Dhawan DK, Mishra AK, Hazari PP. PLOS ONE 2015.

  • 10. LAT1 targeted delivery of methionine-based imaging probe derived from M (III) metal ions for early diagnosis of proliferating tumours using molecular imaging modalities. Hazari PP, Prakash S, Meena VK, Jaswal A, Khurana H, Mishra SK, Bhonsle HK, Singh L, Mishra AK. Curr Cancer Drug Targets. 2015; 14(9):817-31.

 

All for Joomla All for Webmasters